Presented By

Presented By

Continuing Education

Join the RESPTREC family for lifelong learning opportunities and mentorship.


CCCEP: The Education, COPD and Asthma courses have been accredited by Canadian Council on Continuing Education in Pharmacy. Pharmacists have been involved in development of the curricula and review of the content.

The Canadian Council on Continuing Education in Pharmacy has confirmed accreditation as follows:

  • Education for Chronic Disease Management Course - 27.50 CEUs
  • COPD Management Course - 21.50 CEUs
  • Asthma Management Course - 17.50 CEUs

Resources: Download or order RESPTREC resources:

  • Asthma Medications Brochure
  • COPD Medications Brochure
  • Delivery Device Instructions
  • Delivery Device Mastery Sheets

Webinars: Webinars on the most recent research, position papers, guidelines, topics are presented by leading experts in the field quarterly. 15 sites across western Canada participate. For those graduates who are unable to join a live session can access the presentations on-line, following the Webinar. Questions are posted following viewing of the presentation and a continuing education certificate can be printed for your records.

Current News

For your convenience RESPTREC provides links to research articles, announcements, studies and other news updates which are posted daily onto the website. Reading these articles can be used towards recertification and continuing education.

Watch for upcoming opportunities!

CTS position statement: Pharmacotherapy in patients with COPD—An update
Dec 13, 2017

This position statement is an evolution towards personalized treatment, compared to the previous published CTS COPD guideline. It promotes approaches to match treatment decisions based on symptom burden and risk of future exacerbations. 

CTS position statement: Recognition and management of severe asthma
Dec 13, 2017

This CTS Statement reviews existing and emerging therapies for severe asthma, presents key messages for phenotyping individuals with severe asthma and suggests phenotype-specific targeted therapies.

Influenza: 2017–2018 Season Update
Dec 13, 2017

American Thoracic Society Patient Education & Information Series 2017–2018 Season Update on Prevention and Treatment of Influenza Infection

A Practical Approach to Severe Asthma in Children
Dec 11, 2017

Management of severe childhood asthma refractory to traditional therapies involves considering the various biologic and other newly approved treatments, as well as emerging therapies based on the individual patient characteristics.

Consuming sugary drinks during pregnancy may increase asthma risk in mid-childhood
Dec 11, 2017

Children between the ages of 7 and 9 may be at greater risk for developing asthma if they consumed high amounts of fructose in early childhood or their mothers drank a lot of sugar-sweetened beverages while pregnant, according to new research

Sleep as a New Target for Improving Outcomes in Idiopathic Pulmonary Fibrosis
Dec 11, 2017

Sleep in patients with IPF is significantly impaired, with alterations in sleep architecture, changes in sleep breathing pattern, and decreases in oxygen saturation mainly during vulnerable rapid eye movement sleep. There also is evidence that OSA has an increased prevalence in IPF patients

COPD-OSA Overlap Syndrome
Dec 11, 2017

The recognition of coexisting OSA in patients with COPD has important clinical relevance, as the survival of patients with overlap syndrome that is not treated with nocturnal positive airway pressure is significantly inferior to that of patients with overlap syndrome that is appropriately treated.

Tracheobronchopathy From Inhaled Corticosteroids
Dec 11, 2017

The benefits of ICS therapy in patients with asthma and COPD are well recognized. The authors concur that ICSs should be used in concordance with published national and international guidelines. However, an important purpose of this review is to heighten clinician awareness of airway-related sequelae and complications associated with ICSs.&…

Lung Manifestations in the Rheumatic Diseases
Dec 11, 2017

Lung ailments in rheumatic diseases present unique challenges for diagnosis and management and are a source of significant morbidity and mortality for patients.  This discussion focuses on interstitial and airway manifestations, given the significant morbidity associated with these conditions.

Methacholine Challenge Testing: A Novel Method for Measuring PD20
Dec 11, 2017

This study describes a novel, simple, repeatable method for conducting methacholine challenges using new nebulizer technology. Importantly, the method meets recommendations set out in the new guideline

Commonly Used Patient-Reported Outcomes Do Not Improve Prediction of COPD Exacerbations
Dec 11, 2017

Some domains of patient-reported outcomes are independently associated with exacerbations but do not lead to clearly improved prediction when added to established indices to predict exacerbations. There is still much room for improvement in the prediction of exacerbations.

Effect of Statins on COPD
Dec 11, 2017

The findings from a systematic review suggest a role for statin drugs in patients with COPD and coexisting cardiovascular disease, evidence of increased systemic inflammation, or hyperlipidemia with respect to improving exercise tolerance and pulmonary function

Home supply of emergency oral steroids and reduction in asthma healthcare utilization
Dec 06, 2017

Incorporation of home emergency oral steroids into the home management plan of children with moderate-to-severe asthma can reduce asthma related Emergency Department visits.

Respiratory adverse effects of opioids for breathlessness
Dec 06, 2017

A meta-analysis found no evidence of significant or clinically relevant respiratory adverse effects of opioids for chronic breathlessness. Larger studies designed to detect respiratory adverse effects are needed.

Predictors of pneumonia in lower respiratory tract infections
Dec 06, 2017

In routine practice, radiograph-confirmed pneumonia as a short-term complication of lower respiratory tract infections is very uncommon (one in 270). Pulse oximetry may aid the diagnosis of pneumonia in this setting.

RESPTREC™    Advance your skills. Be a leader. | Twitter Facebook